Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer
Nom du journal : Br J Cancer
Année : 2015
Volume : 113
Page de départ : 585
Page de fin : 594